IRIS
ALUNNO, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.016
AS - Asia 1.211
EU - Europa 966
SA - Sud America 203
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 4.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.984
SG - Singapore 591
IE - Irlanda 274
CN - Cina 246
BR - Brasile 182
HK - Hong Kong 136
RU - Federazione Russa 130
TR - Turchia 128
DE - Germania 121
SE - Svezia 102
UA - Ucraina 85
IT - Italia 83
GB - Regno Unito 55
VN - Vietnam 40
FI - Finlandia 34
IN - India 23
FR - Francia 21
CA - Canada 18
BE - Belgio 11
NL - Olanda 11
PL - Polonia 11
IQ - Iraq 9
JP - Giappone 8
AR - Argentina 7
BD - Bangladesh 7
CO - Colombia 5
ES - Italia 5
MX - Messico 5
AU - Australia 4
CH - Svizzera 4
EU - Europa 4
MA - Marocco 4
NP - Nepal 4
PK - Pakistan 4
ZA - Sudafrica 4
DZ - Algeria 3
EC - Ecuador 3
HN - Honduras 3
LT - Lituania 3
VE - Venezuela 3
AT - Austria 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ID - Indonesia 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
NE - Niger 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.420
Salva come PNG Salva come JPEG
Città #
Jacksonville 326
Chandler 315
Singapore 303
Dublin 266
Dallas 200
Hong Kong 135
Santa Clara 120
Boardman 103
Ashburn 81
Izmir 78
New York 65
Nanjing 53
Wilmington 53
Lawrence 48
Princeton 48
Beijing 47
The Dalles 38
Los Angeles 35
Moscow 34
San Mateo 34
Ann Arbor 27
L'aquila 22
Nanchang 20
São Paulo 18
Munich 16
Seattle 16
Hefei 15
Pescara 15
Dearborn 14
Des Moines 14
Milan 14
Shanghai 14
Frankfurt am Main 13
Columbus 12
Ho Chi Minh City 11
Woodbridge 11
Chennai 10
Hanoi 10
Helsinki 10
Verona 10
Council Bluffs 9
Jiaxing 9
Norwalk 9
Tianjin 9
Warsaw 9
Brussels 7
Hebei 7
Mountain View 7
Rio de Janeiro 7
Brooklyn 6
Chicago 6
Philadelphia 6
Rome 6
San Francisco 6
Tokyo 6
Toronto 6
Amsterdam 5
Brasília 5
Montreal 5
Pune 5
Zhengzhou 5
Atlanta 4
Baghdad 4
Belo Horizonte 4
Berlin 4
Bremen 4
Changsha 4
Dong Ket 4
Falkenstein 4
Hangzhou 4
Leuven 4
London 4
Ningbo 4
Shenyang 4
Bogotá 3
Bragança Paulista 3
Cedar Knolls 3
Denver 3
Falls Church 3
Forest City 3
Gravataí 3
Jacareí 3
Jinan 3
Jinhua 3
Kunming 3
Manchester 3
Phoenix 3
Porto Alegre 3
Stockholm 3
Uberlândia 3
Alenquer Municipality 2
Amman 2
Ankara 2
Aracaju 2
Araçatuba 2
Bagnolo Mella 2
Boston 2
Brno 2
Campinas 2
Cape Town 2
Totale 2.934
Salva come PNG Salva come JPEG
Nome #
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 136
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study 121
12-MONTH OUTCOMES IN OVERWEIGHT/OBESE USERS WITH MENTAL DISORDERS FOLLOWING A MULTI-ELEMENT TREATMENT INCLUDING DIET, PHYSICAL ACTIVITY, AND POSITIVE THINKING: THE REAL-WORLD ‘AN APPLE A DAY’ CONTROLLED TRIAL 112
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 108
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 107
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 102
Diet in rheumatoid arthritis versus systemic lupus erythematosus: Any differences? 101
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 100
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 97
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 94
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 94
Unmasking the pathogenic role of il-17 axis in primary sj¨ogren’s syndrome: A new era for therapeutic targeting? 92
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 91
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 91
Common Features in Lymphoproliferative Complications in the Course of Primary Sjo‥gren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients 89
EFFICACY AND SAFETY OF RITUXIMAB ORIGINATOR AND BIOSIMILAR IN PRIMARY SJOGREN'S SYNDROME IN A REAL-LIFE SETTING 89
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? 88
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 88
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 88
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome 87
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. 85
CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement. 85
CLINICAL AND IMAGING FEATURES OF ARTICULAR MANIFESTATIONS IN PRIMARY SJOGREN'S SYNDROME: SIMILARITIES AND DIFFERENCES ACCORDING TO THE TIME OF ONSET 83
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 82
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units 82
Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren’s syndrome: retrospective study in a large italian cohort 80
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis 80
Adherence to the Mediterranean diet and the impact on clinical features in primary Sjögren's syndrome 79
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 78
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 77
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 76
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 76
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares 74
Rituximab in primary Sjögren's syndrome: a ten-year journey 73
Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome 73
Characteristics of primary sjögren’s syndrome (PSS) patients with cryoglobulinemia in a large cohort of patients, and differences between hypergammaglobulinemic and cryoglobulinemic vasculitis in PSS 72
The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans. 71
IL-17 PRODUCING DOUBLE NEGATIVE (DN) T CELL PHENOTYPE AND FUNCTION IN PRIMARY SJÖGREN'S SYNDROME 71
Histopathology of salivary glands 71
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis 70
The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren’s Syndrome: Is Uric Acid the Missing Link? 70
Thymic Stromal Lymphopoietin (TSLP) as a Biomarker of Primary Sjogren's Syndrome (pSS) and Related Lymphoma: Results in Independent Cohorts 68
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 67
Rischio cardiovascolare nei pazienti affetti da malattie infiammatorie croniche: valutazione della relazione tra meccanismi immunologici, profilo metabolico e stile di vita 64
The impact of fibromyalgia in spondyloarthritis: From classification criteria to outcome measures 64
PREVALENCE AND PREDICTIVE ROLE OF TRADITIONAL CARDIOVASCULAR RISK FACTORS IN A COHORT OF SJÖGREN'S SYNDROME PATIENTS 62
SpA plus IBD or IBD plus SpA: Does commutative property apply? 61
THU0681 Baseline ESSDAI/DAS scores in 8061 patients with primary sjÖgren syndrome: characterization of systemic disease 61
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome 57
The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren's syndrome 56
OP0044 Antibodies anti-saccharomyces cerevisiae in primary sjÖgren's syndrome: prevalence, clinical associations and possible cross-reactivity with disease specific autoantigens 56
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 55
Electrocardiographic Abnormalities in Hospitalized Patients with COVID-19 and the Associations with Clinical Outcome 54
The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience 45
Neurological Involvement in a Cohort of Primary Sjogren's Syndrome Patients: Results of a Multicenter Italian Study 44
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 44
Different clinical presentations of primary Sjögren's syndrome: Not only a matter of age. Comment on: “Elderly-onset primary Sjögren's syndrome focused on clinical and salivary gland ultrasonographic features by Lee et al. Joint Bone Spine. 2021;88:105132” 43
Totale 4.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021212 0 0 0 0 0 14 46 0 54 14 69 15
2021/2022263 10 11 38 24 8 10 2 15 24 8 24 89
2022/2023810 69 44 17 89 86 96 0 46 318 8 29 8
2023/2024232 23 13 11 18 24 80 1 13 1 14 5 29
2024/20251.121 38 20 99 62 104 99 202 78 221 44 90 64
2025/2026934 110 195 148 190 189 102 0 0 0 0 0 0
Totale 4.484